INTELLIA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
INTELLIA THERAPEUTICS, INC. (NTLA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 276.38 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 4.88K shares, a 99.10% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 271.50K shares, a 80.59% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 19.85K shares, a 69.03% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 223.04K shares, a 14.56% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 935.06K shares, a 58.33% increase from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 590.57K shares, a 199.22% increase from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 197.37K shares, a 42.20% decline from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 341.44K shares, a 51.27% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 276.38K shares 10-Q · filed 2026-08-06 | 296.23K shares derived: sum of 3 quarters · filed 2026-08-06 | 519.27K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 271.50K shares 10-Q · filed 2026-05-11 | 291.35K shares derived: sum of 2 quarters · filed 2026-05-11 | 514.40K shares derived: sum of 3 quarters · filed 2026-05-11 | 1.06M shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 19.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 242.89K shares derived: sum of 2 quarters · filed 2026-02-26 | 784.72K shares derived: sum of 3 quarters · filed 2026-02-26 | 935.06K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 223.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 764.87K shares derived: sum of 2 quarters · filed 2025-11-06 | 915.21K shares 10-Q · filed 2025-11-06 | 979.31K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 541.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 692.17K shares 10-Q · filed 2025-08-07 | 756.26K shares derived: sum of 3 quarters · filed 2025-08-07 | 950.96K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 150.34K shares 10-Q · filed 2025-05-08 | 214.43K shares derived: sum of 2 quarters · filed 2025-05-08 | 409.13K shares derived: sum of 3 quarters · filed 2025-05-08 | 621.35K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 64.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 258.79K shares derived: sum of 2 quarters · filed 2025-02-27 | 471.00K shares derived: sum of 3 quarters · filed 2025-02-27 | 590.57K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 194.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 406.91K shares derived: sum of 2 quarters · filed 2024-11-07 | 526.47K shares 10-Q · filed 2024-11-07 | 593.37K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 212.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 331.77K shares 10-Q · filed 2024-08-08 | 398.67K shares derived: sum of 3 quarters · filed 2024-08-08 | 467.38K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 119.56K shares 10-Q · filed 2024-05-09 | 186.46K shares derived: sum of 2 quarters · filed 2024-05-09 | 255.17K shares derived: sum of 3 quarters · filed 2024-05-09 | 285.09K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 66.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 135.61K shares derived: sum of 2 quarters · filed 2024-02-22 | 165.53K shares derived: sum of 3 quarters · filed 2024-02-22 | 197.37K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 68.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 98.64K shares derived: sum of 2 quarters · filed 2023-11-09 | 130.47K shares 10-Q · filed 2023-11-09 | 176.22K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 29.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 61.76K shares 10-Q · filed 2023-08-03 | 107.50K shares derived: sum of 3 quarters · filed 2023-08-03 | 162.24K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 31.84K shares 10-Q · filed 2023-05-04 | 77.58K shares derived: sum of 2 quarters · filed 2023-05-04 | 132.33K shares derived: sum of 3 quarters · filed 2023-05-04 | 191.62K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 45.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 100.49K shares derived: sum of 2 quarters · filed 2023-02-23 | 159.79K shares derived: sum of 3 quarters · filed 2023-02-23 | 341.44K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 54.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 114.04K shares derived: sum of 2 quarters · filed 2022-11-03 | 295.69K shares 10-Q · filed 2022-11-03 | 437.15K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 59.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 240.95K shares 10-Q · filed 2022-08-04 | 382.41K shares derived: sum of 3 quarters · filed 2022-08-04 | 643.43K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 181.65K shares 10-Q · filed 2022-05-05 | 323.11K shares derived: sum of 2 quarters · filed 2022-05-05 | 584.14K shares derived: sum of 3 quarters · filed 2022-05-05 | 752.96K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 141.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 402.49K shares derived: sum of 2 quarters · filed 2022-02-24 | 571.31K shares derived: sum of 3 quarters · filed 2022-02-24 | 700.70K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 261.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 429.85K shares derived: sum of 2 quarters · filed 2021-11-04 | 559.24K shares 10-Q · filed 2021-11-04 | 651.41K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 168.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 298.21K shares 10-Q · filed 2021-08-05 | 390.39K shares derived: sum of 3 quarters · filed 2021-08-05 | 586.85K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 129.39K shares 10-Q · filed 2021-05-06 | 221.57K shares derived: sum of 2 quarters · filed 2021-05-06 | 418.03K shares derived: sum of 3 quarters · filed 2021-05-06 | 479.79K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 92.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 288.64K shares derived: sum of 2 quarters · filed 2021-02-26 | 350.39K shares derived: sum of 3 quarters · filed 2021-02-26 | 523.17K shares 10-K · filed 2021-02-26 |
| 2020-09-30 | 196.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 258.22K shares derived: sum of 2 quarters · filed 2020-11-05 | 431.00K shares 10-Q · filed 2020-11-05 | 527.26K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 61.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 234.54K shares 10-Q · filed 2020-08-06 | 330.79K shares derived: sum of 3 quarters · filed 2020-08-06 | 480.33K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 172.78K shares 10-Q · filed 2020-05-07 | 269.04K shares derived: sum of 2 quarters · filed 2020-05-07 | 418.57K shares derived: sum of 3 quarters · filed 2020-05-07 | 578.94K shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 96.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 245.79K shares derived: sum of 2 quarters · filed 2020-02-27 | 406.16K shares derived: sum of 3 quarters · filed 2020-02-27 | 527.90K shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 149.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 309.90K shares derived: sum of 2 quarters · filed 2019-10-31 | 431.64K shares 10-Q · filed 2019-10-31 | |
| 2019-06-30 | 160.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 282.11K shares 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | 121.74K shares 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | 652.97K shares 10-K · filed 2019-02-27 | |||
| 2018-06-30 | 28.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 45.26K shares 10-Q · filed 2018-08-01 | 697.11K shares derived: sum of 3 quarters · filed 2018-08-01 | 890.60K shares derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | 17.22K shares 10-Q · filed 2018-05-01 | 669.08K shares derived: sum of 2 quarters · filed 2018-05-01 | 862.57K shares derived: sum of 3 quarters · filed 2018-05-01 | 898.10K shares derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | 651.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 845.35K shares derived: sum of 2 quarters · filed 2018-03-14 | 880.88K shares derived: sum of 3 quarters · filed 2018-03-14 | 884.16K shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 193.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 229.02K shares derived: sum of 2 quarters · filed 2017-10-31 | 232.31K shares 10-Q · filed 2017-10-31 | 255.84K shares derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | 35.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | 38.82K shares 10-Q · filed 2017-08-01 | 62.35K shares derived: sum of 3 quarters · filed 2017-08-01 | |
| 2017-03-31 | 3.28K shares 10-Q · filed 2017-05-02 | 26.81K shares derived: sum of 2 quarters · filed 2017-05-02 | ||
| 2016-12-31 | 23.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | 30.61K shares 10-K · filed 2017-03-14 | ||
| 2016-09-30 | 7.08K shares 10-Q · filed 2016-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |